Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies
Manu Shankar‐Hari, Thierry Calandra, Miguel P. Soares, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 4, pp. 323-336
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Enhancing sepsis biomarker development: key considerations from public and private perspectives
Jean‐François Llitjos, Enitan D. Carrol, Marcin F. Osuchowski, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 16
The 2024 Phoenix Sepsis Score Criteria: Part 5, What About “Parsimony” in the Criteria—Is Less Really More?
Adrienne G. Randolph, Mark W. Hall, Niranjan Kissoon, et al.
Pediatric Critical Care Medicine (2025) Vol. 26, Iss. 2, pp. e266-e271
Closed Access | Times Cited: 5
The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial
Jianfeng Wu, Fei Pei, Lixin Zhou, et al.
BMJ (2025), pp. e082583-e082583
Closed Access | Times Cited: 2
Sepsis and Septic Shock
Nuala J. Meyer, Hallie C. Prescott
New England Journal of Medicine (2024) Vol. 391, Iss. 22, pp. 2133-2146
Closed Access | Times Cited: 13
Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis
Massimo Girardis, Sascha David, Ricard Ferrer, et al.
Intensive Care Medicine (2024) Vol. 50, Iss. 10, pp. 1580-1592
Closed Access | Times Cited: 10
Dysregulation of neutrophil in sepsis: recent insights and advances
Ji Zhang, Yuwen Shao, Jingyi Wu, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Susceptibility to childhood sepsis, contemporary management, and future directions
Michael J. Carter, Enitan D. Carrol, Suchitra Ranjit, et al.
The Lancet Child & Adolescent Health (2024) Vol. 8, Iss. 9, pp. 682-694
Open Access | Times Cited: 7
Identifying septic shock subgroups to tailor fluid strategies through multi-omics integration
Zhongheng Zhang, Lin Chen, Bin Sun, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Sepsis: key insights, future directions, and immediate goals. A review and expert opinion
Ignacio Martín‐Loeches, Mervyn Singer, Marc Léone
Intensive Care Medicine (2024) Vol. 50, Iss. 12, pp. 2043-2049
Closed Access | Times Cited: 5
Immune Cell-Based versus Albumin-Based Ratios as Outcome Predictors in Critically Ill COVID-19 Patients
Snježana Zeba, Maja Šurbatović, Ivo Udovičić, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 73-90
Open Access
Sepsis subtypes and differential treatment response to vitamin C: biological sub-study of the LOVIT trial
Jennifer Rynne, Mia Mosavie, Marie-Hélène Masse, et al.
Intensive Care Medicine (2025)
Closed Access
Integration of single-cell RNA sequencing and network pharmacology to elucidate the effect of Yantiao Formula on alleviating ALI by regulating the polarization of alveolar macrophages
Liu Deng, Yifei Zhang, Bufan Bai, et al.
Journal of Ethnopharmacology (2025), pp. 119436-119436
Open Access
Clinical subtypes in critically ill patients with sepsis: validation and parsimonious classifier model development
Rombout B. E. van Amstel, Emma Rademaker, Jason Kennedy, et al.
Critical Care (2025) Vol. 29, Iss. 1
Open Access
Programmed cell death markers in COVID-19 survivors with and without sepsis
Chandra Shekar Mallarpu, Srinivasa Ikswaja Chelluri, Tapaswi Krishna Katragadda, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
LAMP2-FLOT2 interaction enhances autophagosome-lysosome fusion to protect the septic heart in response to ILC2
Rongjiao Shao, Weizhuo Liu, Yuxiao Feng, et al.
Autophagy (2025), pp. 1-23
Open Access
Cycloastragenol Reduces Inflammation in CLP-induced Septic Mice by Suppressing TLR4 Signaling Pathways
Guang‐Hong Chen, Weihong Wang, Baoyi Guan, et al.
Phytomedicine (2025), pp. 156645-156645
Closed Access
Activated Notch1 promotes macrophage polarization and exacerbates sepsis-induced acute lung injury via β-catenin/NF-κB signaling
Zhi Liu, Yuxi Lei, Jing Zuo, et al.
Biochemical Pharmacology (2025), pp. 116892-116892
Closed Access
Dynamic risk stratification and treatment optimization in sepsis: the role of NLPR
Qiqi Chen, Ming Zhang, Yuxin Xia, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
A narrative review of the pathophysiology of sepsis in sub-Saharan Africa: Exploring the potential for corticosteroid therapy
Phoebe Gruccio, W. Girard, Amelia D Badipour, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 4, pp. e0004429-e0004429
Open Access
Charting a course for precision therapy trials in sepsis
Robert B. Lindell, Nuala J. Meyer
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 4, pp. 265-267
Closed Access | Times Cited: 4
Biological basis of critical illness subclasses: from the bedside to the bench and back again
Joseph Stevens, Oğuzhan Tezel, Valentina Bonnefil, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 4
Aiming for precision: personalized medicine through sepsis subtyping
Aryna Kolodyazhna, W. Joost Wiersinga, Tom van der Poll
Burns & Trauma (2025) Vol. 13
Open Access
Sepsis subphenotypes, theragnostics and personalized sepsis care
David Antcliffe, Aidan Burrell, Andrew Boyle, et al.
Intensive Care Medicine (2025)
Open Access
Informative Subtyping of Patients with Sepsis
John Cafferkey, Manu Shankar‐Hari
Seminars in Respiratory and Critical Care Medicine (2024) Vol. 45, Iss. 04, pp. 516-522
Closed Access | Times Cited: 1
The delivery of PD-L1 siRNA by neutrophil-targeted lipid nanoparticles effectively ameliorates sepsis
Cheng‐long Zhu, Yi Wang, Shi-chun Ren, et al.
Shock (2024) Vol. 62, Iss. 5, pp. 707-715
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top